Biofrontera (BFRI) Director Kevin D. Weber Receives 20,000-Share Award

What Happened

• Kevin Daniel Weber, a director of Biofrontera Inc. (BFRI), received a derivative award on March 4, 2026 covering 20,000 shares. The Form 4 reports an acquisition price of $0.00 and a reported value of $0 for the award (derivative security).

Key Details

• Transaction date: 2026-03-04; Report filed: 2026-03-06.
• Reported terms: 20,000 derivative shares acquired @ $0.00; total reported value $0.
• Vesting: The award vests in twelve equal monthly installments beginning April 4, 2026 (Footnote F1).
• Notes: The filing states “options with different terms are not included” (Footnote F2).
• Shares owned after transaction: Not specified in the provided filing.

Context

• This was a grant/award of a derivative security (an option-type award per the footnote). Such awards are typically part of director compensation and are not the same as an open-market purchase or sale. The filing does not indicate any immediate sale or cashless exercise.